Filed before 2025Filed 21 May 2014
Trident Pharmaceuticals Inc raised $275K
Trident Pharmaceuticals Inc, a technology company based in Boston, MA, raised $275K in a new equity round, according to a filing dated 21 May 2014.
Raises filed before 2025 are not checked for a public announcement.
- Filed
- 21 May 2014
- Round
- Equity round
- Amount sold
- $275K
- Offering size
- $826K
- Investors so far
- 4
- Based in
- Boston, MA
Investors on the board
- Cure Ventures
- GSR Ventures
- ExSight ONL SC
- 8th Line
- ExSight Fund
Firms come from the venture funds whose filings name a director of this company.
Who is on the board
2 directors of this company are named on venture funds' filings. Sign in free with Google to see who, the full filing, and a short list of rounds like this each morning.
Sign in with GoogleHow it compares
Larger than 4% of the 1,533 tracked raises with an amount filed in 2014, and than 5% of the 752 in technology.
Trident Pharmaceuticals Inc in public filings
| Filed | Filing | Sold | Raise |
|---|---|---|---|
| 21 May 2014 | New filing | $275K | This raise |
More with Cure Ventures on the board
- Tasca Therapeutics Corp$48.1M
- Crosslink Therapeutics Inc.$4.25M
- Alessa Therapeutics, Inc.$25.4M
- Deep 6 AI Inc.$26.9M
Other unannounced rounds
- DVx Atomic Co.$18.5M
- Aperio Systems, Inc.$1.6M
- Twin Health, Inc.$59M
- Scoring Factory AI Inc.$500K
- Royal & Pelham, Inc.$5.4M
- SPECTRA Holdings US, Ltd.$2.5M
Seen it announced?
Send the link and the check will look at it.